Osterweis Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoZone
AZO
|
+$27.9M |
| 2 |
Broadcom
AVGO
|
+$26.2M |
| 3 |
UnitedHealth
UNH
|
+$24.8M |
| 4 |
Advanced Micro Devices
AMD
|
+$10.9M |
| 5 |
Agilysys
AGYS
|
+$9.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$41.9M |
| 2 |
Micron Technology
MU
|
+$23.8M |
| 3 |
Teleflex
TFX
|
+$16.4M |
| 4 |
Kenvue
KVUE
|
+$12.9M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$9.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.77% |
| 2 | Healthcare | 15.05% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Industrials | 9% |
| 5 | Financials | 5.86% |
Similar funds
Osterweis Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Osterweis Capital Management held 204 positions worth $1.94B, up 14% from $1.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Osterweis Capital Management withdrew a net $187M in Q2 2024, closing 9 positions and reducing 48 holdings. Its most notable exit was Sysco, an estimated $41.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Osterweis Capital Management opened a new position in Agilysys worth $10.7M.
- Osterweis Capital Management's largest Q2 2024 buy was Agilysys: 102,655 shares worth $10.7M.
- Osterweis Capital Management added most to AutoZone in Q2 2024, an estimated $27.9M increase.
- Osterweis Capital Management's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $23.8M.
- Osterweis Capital Management fully exited Sysco in Q2 2024, selling an estimated $41.9M.
- Osterweis Capital Management's ten largest holdings make up 34% of its $1.94B portfolio in Q2 2024.
- Osterweis Capital Management opened 11 new positions and closed 9 in Q2 2024.
- Osterweis Capital Management's portfolio value rose 14% quarter-over-quarter to $1.94B.
Based on Osterweis Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.